Acasti Pharma Statistics Share Statistics Acasti Pharma has 10.14M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 10.14M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) 0% Shares Floating 4.65M Failed to Deliver (FTD) Shares 5,553 FTD / Avg. Volume 16.7%
Short Selling Information The latest short interest is 154.19K, so 1.52% of the outstanding
shares have been sold short.
Short Interest 154.19K Short % of Shares Out 1.52% Short % of Float 1.93% Short Ratio (days to cover) 7.75
Valuation Ratios The PE ratio is -3.11 and the forward
PE ratio is -2.37.
Acasti Pharma's PEG ratio is
0.07.
PE Ratio -3.11 Forward PE -2.37 PS Ratio 0 Forward PS 27 PB Ratio 0.6 P/FCF Ratio -2.66 PEG Ratio 0.07
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Acasti Pharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 11.77,
with a Debt / Equity ratio of 0.
Current Ratio 11.77 Quick Ratio 11.77 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-398.97K Employee Count 32 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 40.42% in the
last 52 weeks. The beta is 1.52, so Acasti Pharma's
price volatility has been higher than the market average.
Beta 1.52 52-Week Price Change 40.42% 50-Day Moving Average 3.11 200-Day Moving Average 2.99 Relative Strength Index (RSI) 54.72 Average Volume (20 Days) 33,247
Income Statement
Revenue n/a Gross Profit n/a Operating Income n/a Net Income -12.77M EBITDA n/a EBIT n/a Earnings Per Share (EPS) -0.79
Full Income Statement Balance Sheet The company has 22.13M in cash and 0 in
debt, giving a net cash position of 22.13M.
Cash & Cash Equivalents 22.13M Total Debt n/a Net Cash n/a Retained Earnings -220.69M Total Assets 71.99M Working Capital 20.78M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -14.9M
and capital expenditures 0, giving a free cash flow of -14.9M.
Operating Cash Flow -14.9M Capital Expenditures n/a Free Cash Flow -14.9M FCF Per Share -1.23
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields ACST does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for ACST is $10,
which is 196.7% higher than the current price. The consensus rating is "Strong Buy".
Price Target $10 Price Target Difference 196.7% Analyst Consensus Strong Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 10, 2023. It was a
backward
split with a ratio of 1:6.
Last Split Date Jul 10, 2023 Split Type backward Split Ratio 1:6
Scores Altman Z-Score -0.55 Piotroski F-Score 2
